Fundraising FoxMyriad
3 known investors
Find your way into Myriad
Myriad provides germline and tumor genomic testing across hereditary cancer, prenatal and reproductive health, prostate cancer, and pharmacogenomics for mental health medications. It supplies patients and healthcare providers with genetic screening results and AI-derived insights to inform diagnosis, risk assessment, and treatment decisions.
Investors · 3
OrbiMedlisted by OrbiMedNew York · $1M – $75M
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
Hack VCreportedPalo Alto · $3M
How we know: funding news · Not right? Tell us
Ten VCreportedMenlo Park · $250K – $1.5Mvia Daniel Ramirez · inferred
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Myriad do?
- Myriad provides germline and tumor genomic testing across hereditary cancer, prenatal and reproductive health, prostate cancer, and pharmacogenomics for mental health medications. It supplies patients and healthcare providers with genetic screening results and AI-derived insights to inform diagnosis, risk assessment, and treatment decisions.
- Who are Myriad's investors?
- Myriad's investors include OrbiMed, Hack VC, Ten VC.